A48-29948-59050
4 vaccinations
11 coded responses
39 check-ins
11 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 927 / CA
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
-
2021-01-13
Survey response — day 14, dose 1MedDRA: Rash erythematous — Feeling: GoodFree text: On day 8 I got a red raised rash at site about 3x 4 cm , resolved with Benadryl in 24 hoursMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-20
-
2021-01-27
Dose 2 — Moderna
- 2021-02-20
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-04-28
- 2021-07-28
-
2021-10-09
Dose 3 — Moderna
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-11-13
-
2021-11-20
Survey response — day 42, dose 3MedDRA: Meniere's disease, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Menieres flare up - occurs every few years , not Covid related .MedDRA releases: 2024-11 · check-in free text available
-
2021-11-20
Report sent to call center — day 42, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-11-29
- 2022-01-08
- 2022-04-09
-
2022-04-20
Dose 4 — Pfizer-BioNTech
- 2022-04-20
-
2022-04-21
Survey response — days 1–6 daily, dose 4MedDRA: Pre-existing disease, Tinnitus, Unevaluable event — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Increased tinnitus- have Ménière's disease noted that vaccines increase symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Survey response — days 1–6 daily, dose 4MedDRA: Deafness, Dizziness, Meniere's disease, Pre-existing disease, Tinnitus — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Worsening Menieres symptoms of tinnitis , hearing loss , dizziness - this has occurred with every boosterMedDRA releases: 2024-11 · check-in free text available
-
2022-04-23
Survey response — days 1–6 daily, dose 4MedDRA: Gastrointestinal disorder — Feeling: GoodFree text: Ménière's disease mild symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-04-24
Survey response — days 1–6 daily, dose 4MedDRA: Meniere's disease — Feeling: GoodFree text: Ménière's symptoms seem to worsen every time I get boosterMedDRA releases: 2024-11 · check-in free text available
-
2022-04-25
Survey response — days 1–6 daily, dose 4MedDRA: Deafness, Dizziness, Tinnitus, Unevaluable event, Vaccine positive rechallenge — Feeling: FairFree text: Ménière's - dizzy, tinnitus , hearing loss. Occurs after I get covid booster every timeMedDRA releases: 2024-11 · check-in free text available
-
2022-04-26
Survey response — days 1–6 daily, dose 4MedDRA: Dizziness, Tinnitus — Feeling: GoodFree text: Tinnitus , mild dizzyMedDRA releases: 2024-11 · check-in free text available
-
2022-04-27
Survey response — day 7, dose 4MedDRA: Dizziness — Feeling: GoodFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
- 2022-05-05
- 2022-05-11
- 2022-05-18
- 2022-05-25
- 2022-06-02
-
2022-07-20
Survey response — 3 months, dose 4MedDRA: Exposure to SARS-CoV-2, Meniere's disease, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Exposure to covid , tested negative Worsening menieres symptoms for two weeksMedDRA releases: 2024-11 · check-in free text available
-
2022-07-20
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-07-21
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-19
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: Covid 7/26MedDRA releases: 2024-11 · check-in free text available
- 2023-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-27 | Moderna | |
| 3 | 2021-10-09 | Moderna | No |
| 4 | 2022-04-20 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 1 — day 14, dose 1
Symptoms: On day 8 I got a red raised rash at site about 3x 4 cm , resolved with Benadryl in 24 hours
Release 10 — day 42, dose 3
Symptoms: Menieres flare up - occurs every few years , not Covid related .
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Increased tinnitus- have Ménière's disease noted that vaccines increase symptoms
Systemic reaction (other): Worsening Menieres symptoms of tinnitis , hearing loss , dizziness - this has occurred with every booster
Systemic reaction (other): Ménière's disease mild symptoms
Systemic reaction (other): Ménière's symptoms seem to worsen every time I get booster
Systemic reaction (other): Ménière's - dizzy, tinnitus , hearing loss. Occurs after I get covid booster every time
Systemic reaction (other): Tinnitus , mild dizzy
Release 11 — day 7, dose 4
Systemic reaction (other): Dizziness
Release 12 — 3 months, dose 4
Symptoms: Exposure to covid , tested negative Worsening menieres symptoms for two weeks
Release 12 — 6 months, dose 4
Symptoms: Covid 7/26
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Meniere's disease | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rash erythematous | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Deafness | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Gastrointestinal disorder | · | · | ✓ |
| SRO | Meniere's disease | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Tinnitus | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
| SRO | Vaccine positive rechallenge | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release